Projects per year
Abstract
BACKGROUND The glucocorticoid dexamethasone prevents nausea and vomiting after surgery, but there is concern that it may increase the risk of surgical-site infection. METHODS In this pragmatic, international, noninferiority trial, we randomly assigned 8880 adult patients who were undergoing nonurgent, noncardiac surgery of at least 2 hours’ duration, with a skin incision length longer than 5 cm and a postoperative overnight hospital stay, to receive 8 mg of intravenous dexamethasone or matching placebo while under anesthesia. Randomization was stratified according to diabetes status and trial center. The primary outcome was surgical-site infection within 30 days after surgery. The prespecified noninferiority margin was 2.0 percentage points. RESULTS A total of 8725 participants were included in the modified intention-to-treat population (4372 in the dexamethasone group and 4353 in the placebo group), of whom 13.2% (576 in the dexamethasone group and 572 in the placebo group) had diabetes mellitus. Of the 8678 patients included in the primary analysis, surgical-site infection occurred in 8.1% (354 of 4350 patients) assigned to dexamethasone and in 9.1% (394 of 4328) assigned to placebo (risk difference adjusted for diabetes status, −0.9 percentage points; 95.6% confidence interval [CI], −2.1 to 0.3; P<0.001 for noninferiority). The results for superficial, deep, and organ-space surgical-site infections and in patients with diabetes were similar to those of the primary analysis. Postoperative nausea and vomiting in the first 24 hours after surgery occurred in 42.2% of patients in the dexamethasone group and in 53.9% in the placebo group (risk ratio, 0.78; 95% CI, 0.75 to 0.82). Hyperglycemic events in patients without diabetes occurred in 22 of 3787 (0.6%) in the dexamethasone group and in 6 of 3776 (0.2%) in the placebo group. CONCLUSIONS Dexamethasone was noninferior to placebo with respect to the incidence of surgical-site infection within 30 days after nonurgent, noncardiac surgery.
Original language | English |
---|---|
Pages (from-to) | 1731-1741 |
Number of pages | 11 |
Journal | The New England Journal of Medicine |
Volume | 384 |
Issue number | 18 |
DOIs | |
Publication status | Published - 6 May 2021 |
Projects
- 2 Finished
-
Improving the Impact of Perioperative Clinical Trials
National Health and Medical Research Council (NHMRC) (Australia)
1/01/18 → 31/12/22
Project: Research
-
Perioperative Administration of Dexamethasone and Infection- The PADDI trial
Corcoran, T., Bach, L., Chan, M. T. V., Cheng, A., Forbes, A., Ho, K., Leslie, K., Myles, P. & Short, T.
National Health and Medical Research Council (NHMRC) (Australia)
1/11/15 → 31/07/21
Project: Research